Triple
T10292090
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CD38 |
E241387
|
entity |
| Predicate | targetOf |
P860
|
FINISHED |
| Object |
daratumumab
Daratumumab is a monoclonal antibody drug used primarily to treat multiple myeloma by targeting and destroying malignant plasma cells.
|
E852348
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d381aaafc08190af475ef58dc16aba |
elicitation | completed |
| NER | batch_69d4d2d35f048190a215493acdf1f718 |
ner | completed |
| NED1 | batch_69d6f85dcbac8190a2ac66354010e328 |
ned_source_triple | completed |
| NED2 | batch_69d6fd879ab88190b0a47295f5d7ad4d |
ned_description | completed |
| NEDg | batch_69d6fcaee26c8190a19f7d07a63531f6 |
nedg | completed |
Created at: April 6, 2026, 11:42 a.m.